Related Experiment Videos
Bisphosphonates, cancer, and osteonecrosis--a single practice experience
Michael J Guarino1, Constance E Hill, Ketan Patel
1Medical Oncology Hematology Consultants, Newark, DE, USA.
Delaware Medical Journal
|June 17, 2005
Summary
Intravenous bisphosphonates are increasingly used to prevent bone problems in cancer patients. This article examines their usage patterns, patient demographics, and a specific side effect.
Area of Science:
- Oncology
- Pharmacology
Background:
- Intravenous bisphosphonates are crucial for managing skeletal-related events in cancer patients.
- Their use has expanded significantly in recent years.
Observation:
- This article investigates the prevalence of intravenous bisphosphonate administration.
- It also analyzes the demographic characteristics of the patient population receiving these treatments.
- The occurrence of a specific adverse side effect is also examined.
Findings:
- The study explores the real-world application of intravenous bisphosphonates.
- Key demographic factors influencing treatment and side effect occurrence are identified.
Implications:
- Understanding usage patterns can optimize patient care and resource allocation.
- Identifying risk factors for side effects aids in proactive management and improved patient outcomes.